RESUMEN
Introduction: The early transcription unit 3 (E3) of human adenoviruses (HAdVs) encodes several immunoevasins, including the E3/49K protein, which is unique for species D of HAdVs. It is expressed as surface transmembrane protein and shed. E3/49K of HAdV-D64 binds to the protein tyrosine phosphatase surface receptor CD45, thereby modulating activation of T and NK cells. Methods: Considering that E3/49K represents the most polymorphic viral protein among species D HAdVs, we demonstrate here that all tested E3/49K orthologs bind to the immunologically important regulator CD45. Thus, this feature is conserved regardless of the pathological associations of the respective HAdV types. Results: It appeared that modulation of CD45 is a unique property restricted to HAdVs of species D. Moreover, E3/49K treatment inhibited B cell receptor (BCR) signaling and impaired BCR signal phenotypes. The latter were highly comparable to B cells having defects in the expression of CD45, suggesting E3/49K as a potential tool to investigate CD45 specific functions. Conclusion: We identified B cells as new direct target of E3/49K-mediated immune modulation, representing a novel viral immunosubversive mechanism.
Asunto(s)
Proteínas E3 de Adenovirus , Adenovirus Humanos , Linfocitos B , Antígenos Comunes de Leucocito , Receptores de Antígenos de Linfocitos B , Transducción de Señal , Humanos , Receptores de Antígenos de Linfocitos B/metabolismo , Receptores de Antígenos de Linfocitos B/inmunología , Transducción de Señal/inmunología , Antígenos Comunes de Leucocito/metabolismo , Antígenos Comunes de Leucocito/inmunología , Adenovirus Humanos/inmunología , Proteínas E3 de Adenovirus/inmunología , Proteínas E3 de Adenovirus/metabolismo , Proteínas E3 de Adenovirus/genética , Linfocitos B/inmunología , Linfocitos B/metabolismo , Infecciones por Adenovirus Humanos/inmunología , Infecciones por Adenovirus Humanos/virología , Infecciones por Adenovirus Humanos/metabolismo , Células HEK293RESUMEN
The human adenovirus type 5 (HAdV5) infects epithelial cells of the upper and lower respiratory tract. The virus causes lysis of infected cells and thus enables spread of progeny virions to neighboring cells for the next round of infection. The mechanism of adenovirus virion egress across the nuclear barrier is not known. The human adenovirus death protein (ADP) facilitates the release of virions from infected cells and has been hypothesized to cause membrane damage. Here, we set out to answer whether ADP does indeed increase nuclear membrane damage. We analyzed the nuclear envelope morphology using a combination of fluorescence and state-of-the-art electron microscopy techniques, including serial block-face scanning electron microscopy and electron cryo-tomography of focused ion beam-milled cells. We report multiple destabilization phenotypes of the nuclear envelope in HAdV5 infection. These include reduction of lamin A/C at the nuclear envelope, large-scale membrane invaginations, alterations in double membrane separation distance and small-scale membrane protrusions. Additionally, we measured increased nuclear membrane permeability and detected nuclear envelope lesions under cryoconditions. Unexpectedly, and in contrast to previous hypotheses, ADP did not have an effect on lamin A/C reduction or nuclear permeability.
Asunto(s)
Proteínas E3 de Adenovirus/metabolismo , Adenovirus Humanos/metabolismo , Membrana Nuclear/metabolismo , Proteínas E3 de Adenovirus/genética , Línea Celular Tumoral , Humanos , Lamina Tipo A/metabolismo , Microscopía Electrónica de Rastreo , PermeabilidadRESUMEN
Human adenovirus types 4 (HAdV4) and 7 (HAdV7) often lead to severe respiratory diseases and occur epidemically in children, adults, immune deficiency patients, and other groups, leading to mild or severe symptoms and even death. However, no licensed adenovirus vaccine has been approved in the market for general use. E3 genes of adenovirus are generally considered nonessential for virulence and replication; however, a few studies have demonstrated that the products of these genes are also functional. In this study, most of the E3 genes were deleted, and two E3-deleted recombinant adenoviruses (ΔE3-rAdVs) were constructed as components of the vaccine. After E3 deletion, the replication efficiencies and cytopathogenicity of ΔE3-rAdVs were reduced, indicating that ΔE3-rAdVs were attenuated after E3 genes deletion. Furthermore, single immunization with live-attenuated bivalent vaccine candidate protects mice against challenge with wild-type human adenovirus types 4 and 7, respectively. Vaccinated mice demonstrated remarkably decreased viral loads in the lungs and less lung pathology compared to the control animals. Taken together, our study confirms the possibility of the two live-attenuated viruses as a vaccine for clinic use and illustrates a novel strategy for the construction of an adenovirus vaccine.
Asunto(s)
Proteínas E3 de Adenovirus/genética , Infecciones por Adenovirus Humanos/prevención & control , Vacunas contra el Adenovirus/inmunología , Adenovirus Humanos/inmunología , Vacunas Atenuadas/inmunología , Células A549 , Infecciones por Adenovirus Humanos/inmunología , Adenovirus Humanos/clasificación , Animales , Línea Celular , Femenino , Eliminación de Gen , Células HEK293 , Humanos , Ratones , Ratones Endogámicos BALB C , Carga ViralRESUMEN
Efficacy of oncolytic, conditionally-replicating adenovirus (CRAd) vectors can be enhanced by "arming" the vector with therapeutic transgenes. We examined whether inclusion of an intact early region 3 (E3) and the reptilian reovirus fusogenic p14 fusion-associated small transmembrane (FAST) protein enhanced vector efficacy. The p14 FAST transgene was cloned between the fiber gene and E4 region, with an upstream splice acceptor for replication-dependent expression from the major late promoter. In A549 cells, this vector expressed p14 FAST protein at very low levels, and showed a poor ability to mediate cell-cell fusion, relative to a similar vector encoding p14 FAST within the E3 deletion. Although expression of E3 proteins from the CRAd increased plaque size, poor expression of p14 FAST protein compromised the fusogenic capacity of the vector. Thus, location of a therapeutic transgene within a CRAd can significantly impact expression of the transgene and is an important consideration in vector design.
Asunto(s)
Proteínas E3 de Adenovirus/genética , Adenovirus Humanos/genética , Vectores Genéticos , Virus Oncolíticos/genética , Transgenes , Proteínas Virales de Fusión/genética , Células A549 , Proteínas E3 de Adenovirus/metabolismo , Adenovirus Humanos/fisiología , Expresión Génica , Genoma Viral , Células HEK293 , Humanos , Virus Oncolíticos/fisiología , Empalme del ARN , Proteínas Virales de Fusión/metabolismoRESUMEN
Hemorrhagic enteritis virus (HEV) is an immunosuppressive adenovirus that causes an acute clinical disease characterized by hemorrhagic gastroenteritis in 4-week-old turkeys and older. Recurrent incidence of secondary infections (e.g., systemic bacterial infections, cellulitis, and elevated mortality), may be associated with the presence of field-type HEV in Canadian turkey farms. We speculate that field-type HEV and vaccine/vaccine-like strains can be differentiated through analysis of the viral genomes, hexon genes, and the specific virulence factors (e.g., ORF1, E3, and fib knob domain). Nine out of sixteen spleens obtained from cases suspected of immunosuppression by HEV were analyzed. The limited data obtained showed that: (1) field-type HEV circulates in many non-vaccinated western Canadian flocks; (2) field-type HEV circulates in vaccinated flocks with increased recurrent bacterial infections; and (3) the existence of novel point mutations in hexon, ORF1, E3, and specially fib knob domains. This is the first publication showing the circulation of wild-type HEV in HEV-vaccinated flocks in Western Canada, and the usefulness of a novel procedure that allows whole genome sequencing of HEV directly from spleens, without passaging in cell culture or passaging in vivo. Further studies focusing more samples are required to confirm our observations and investigate possible vaccination failure.
Asunto(s)
Infecciones por Adenoviridae/veterinaria , Genoma Viral , Enfermedades de las Aves de Corral/virología , Siadenovirus/genética , Pavos/virología , Infecciones por Adenoviridae/epidemiología , Infecciones por Adenoviridae/virología , Proteínas E3 de Adenovirus/química , Proteínas E3 de Adenovirus/genética , Vacunas contra el Adenovirus/inmunología , Animales , Canadá/epidemiología , Proteínas de la Cápside/química , Proteínas de la Cápside/genética , Genes Virales , Glicosilación , Mutación , Sistemas de Lectura Abierta , Siadenovirus/inmunología , Siadenovirus/aislamiento & purificación , Siadenovirus/patogenicidad , Bazo/virología , Proteínas Virales/genética , Factores de Virulencia/genética , Secuenciación Completa del GenomaRESUMEN
Receptor internalization and degradation (RID), is a transmembrane protein coded within the E3 region expression cassette of adenoviruses. RID downregulates the cell surface expression of epidermal growth factor receptor (EGFR), tumor necrosis factor receptor (TNFR), and apoptosis antigen 1 (FAS), causing a reduction of the effects of their respective ligands. In addition, RID inhibits apoptosis by decreasing the secretion of TNF-related apoptosis-inducing ligand (TRAIL) by normal tissue cells. In this article, we report that RID inhibited chemokine expression in human breast cancer cell line MDA-MB-231 but showed no effect in cell line MCF7. These dissimilar results may be due to the different molecular and functional properties of both cell lines. Therefore, it is necessary to replicate this study in other breast cancer cell models.
Asunto(s)
Proteínas E3 de Adenovirus/fisiología , Neoplasias de la Mama/metabolismo , Proteínas de la Membrana/fisiología , FN-kappa B/metabolismo , Factor de Transcripción AP-1/metabolismo , Factor de Necrosis Tumoral alfa/farmacología , Adenoviridae/genética , Proteínas E3 de Adenovirus/genética , Línea Celular Tumoral , Receptores ErbB/metabolismo , Humanos , Células MCF-7 , Proteínas de la Membrana/genética , Receptores del Factor de Necrosis Tumoral/metabolismo , Transducción de Señal/efectos de los fármacos , Receptor fas/metabolismoRESUMEN
The E3 region of all simian and human types classified within species Human mastadenovirus B (HAdV-B) encodes two unique highly conserved ORFs of unknown function designated E3-CR1ß and E3-CR1γ. We generated a HAdV-3 mutant encoding small epitope tags at the N-termini of both E3-CR1ß and E3-CR1γ (HAdV-3 N-tag wt) and a double knock out (HAdV-3 N-tag DKO) mutant virus that does not express either protein. Our studies show that HAdV-3 E3-CR1ß and E3-CR1γ are type I transmembrane proteins that are produced predominantly at late times post infection, are glycosylated, co-localize at the plasma membrane of non-polarized epithelial cells, and interact with each other. At their extreme C-termini HAdV-B E3-CR1ß and E3-CR1γ possess a conserved di-leucine motif followed by a class II PDZ domain binding motif (PBM). HAdV-3 E3-CR1ß and E3-CR1γ are dispensable for virus growth, progeny release, spread, and plaque formation in A549 cells.
Asunto(s)
Proteínas E3 de Adenovirus/química , Proteínas E3 de Adenovirus/metabolismo , Infecciones por Adenovirus Humanos/virología , Adenovirus Humanos/metabolismo , Membrana Celular/virología , Proteínas E3 de Adenovirus/genética , Adenovirus Humanos/química , Adenovirus Humanos/genética , Secuencias de Aminoácidos , Polaridad Celular , Células Epiteliales/virología , Genoma Viral , Humanos , Transporte de ProteínasRESUMEN
Human adenoviruses (HAdVs) are widespread pathogens that cause a number of partially overlapping, species-specific infections associated with respiratory, urinary, gastrointestinal, and ocular diseases. The early 3 (E3) region of adenoviruses is highly divergent between different species, and it encodes a multitude of proteins with immunomodulatory functions. The study of genetic diversity in the E3 region offers a unique opportunity to gain insight into how the various HAdVs have evolutionarily adapted in response to the selection pressures exerted by host immune defenses. The objective of this review was to discuss subversion of host antiviral immune responses by HAdVs, with a focus on suppression of MHC class I antigen presentation, as a window into host-HAdV adaptation.
Asunto(s)
Proteínas E3 de Adenovirus/metabolismo , Infecciones por Adenovirus Humanos/inmunología , Adenovirus Humanos/fisiología , Evasión Inmune , Proteínas E3 de Adenovirus/genética , Presentación de Antígeno , Evolución Molecular , Antígenos de Histocompatibilidad Clase I/metabolismo , Interacciones Huésped-Patógeno , Humanos , Selección GenéticaRESUMEN
The unique repertoire of genes that characterizes the early region 3 (E3) of the different species of human adenovirus (HAdV) likely contributes to their distinct pathogenic traits. The function of many E3 CR1 proteins remains unknown possibly due to unidentified intrinsic properties that make them difficult to express ectopically. This study shows that the species HAdV-B- and HAdV-E-specific E3 CR1 genes can be expressed from vectors carrying the HAdV tripartite leader (TPL) sequence but not from traditional mammalian expression vectors. Insertion of the TPL sequence upstream of the HAdV-B and HAdV-E E3 CR1 open reading frames was sufficient to rescue protein expression from pCI-neo constructs in transfected 293T cells. The detection of higher levels of HAdV-B and HAdV-E E3 CR1 transcripts suggests that the TPL sequence may enhance gene expression at both the transcriptional and translational levels. Our findings will facilitate the characterization of additional AdV E3 proteins.
Asunto(s)
Regiones no Traducidas 5'/genética , Proteínas E3 de Adenovirus/biosíntesis , Proteínas E3 de Adenovirus/genética , Adenovirus Humanos/genética , Expresión Génica Ectópica/genética , Genoma Viral/genética , Adenovirus Humanos/clasificación , Electroporación , Vectores Genéticos/genética , Células HEK293 , Células HeLa , Humanos , Microscopía Fluorescente , Sistemas de Lectura Abierta/genética , Señales de Clasificación de Proteína , Transfección , Proteínas Virales/genéticaRESUMEN
Bats carry diverse RNA viruses, some of which are responsible for human diseases. Compared to bat-borne RNA viruses, relatively little information is known regarding bat-borne DNA viruses. In this study, we isolated and characterized three novel bat adenoviruses (BtAdV WIV9-11) from Rhinolophus sinicus. Their genomes, which are highly similar to each other but distinct from those of previously sequenced adenoviruses (AdVs), are 37 545, 37 566 and 38 073 bp in size, respectively. An unusually large E3 gene was identified in their genomes. Phylogenetic and taxonomic analyses suggested that these isolates represent a distinct species of the genus Mastadenovirus. Cell susceptibility assays revealed a broad cell tropism for these isolates, indicating that they have a potentially wide host range. Our results expand the understanding of genetic diversity of bat AdVs.
Asunto(s)
Proteínas E3 de Adenovirus/genética , Quirópteros/virología , Genoma Viral/genética , Mastadenovirus/clasificación , Mastadenovirus/genética , Animales , Secuencia de Bases , Proteínas de la Cápside/genética , Chlorocebus aethiops , Cricetinae , ADN Viral/genética , Variación Genética/genética , Especificidad del Huésped , Humanos , Macaca mulatta , Filogenia , Análisis de Secuencia de ADN , Porcinos , Tropismo ViralRESUMEN
The E3 transcription unit of human species C adenoviruses (Ads) encodes immunomodulatory proteins that mediate direct protection of infected cells. Recently, we described a novel immunomodulatory function for E3/49K, an E3 protein uniquely expressed by species D Ads. E3/49K of Ad19a/Ad64, a serotype that causes epidemic keratokonjunctivitis, is synthesized as a highly glycosylated type I transmembrane protein that is subsequently cleaved, resulting in secretion of its large ectodomain (sec49K). sec49K binds to CD45 on leukocytes, impairing activation and functions of natural killer cells and T cells. E3/49K is localized in the Golgi/trans-Golgi network (TGN), in the early endosomes, and on the plasma membrane, yet the cellular compartment where E3/49K is cleaved and the protease involved remained elusive. Here we show that TGN-localized E3/49K comprises both newly synthesized and recycled molecules. Full-length E3/49K was not detected in late endosomes/lysosomes, but the C-terminal fragment accumulated in this compartment at late times of infection. Inhibitor studies showed that cleavage occurs in a post-TGN compartment and that lysosomotropic agents enhance secretion. Interestingly, the cytoplasmic tail of E3/49K contains two potential sorting motifs, YXXΦ (where Φ represents a bulky hydrophobic amino acid) and LL, that are important for binding the clathrin adaptor proteins AP-1 and AP-2in vitro Surprisingly, mutating the LL motif, either alone or together with YXXΦ, did not prevent proteolytic processing but increased cell surface expression and secretion. Upon brefeldin A treatment, cell surface expression was rapidly lost, even for mutants lacking all known endocytosis motifs. Together with immunofluorescence data, we propose a model for intracellular E3/49K transport whereby cleavage takes place on the cell surface by matrix metalloproteases.
Asunto(s)
Adenoviridae/inmunología , Proteínas E3 de Adenovirus/química , Membrana Celular/inmunología , Células Epiteliales/inmunología , Fibroblastos/inmunología , Adenoviridae/química , Adenoviridae/patogenicidad , Proteínas E3 de Adenovirus/genética , Proteínas E3 de Adenovirus/inmunología , Secuencias de Aminoácidos , Brefeldino A/farmacología , Línea Celular Tumoral , Membrana Celular/virología , Endosomas/inmunología , Endosomas/virología , Células Epiteliales/efectos de los fármacos , Células Epiteliales/virología , Fibroblastos/efectos de los fármacos , Fibroblastos/virología , Expresión Génica , Regulación de la Expresión Génica , Interacciones Huésped-Patógeno/inmunología , Humanos , Inmunomodulación , Células Jurkat , Lisosomas/inmunología , Lisosomas/virología , Datos de Secuencia Molecular , Cultivo Primario de Células , Estructura Terciaria de Proteína , Proteolisis , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/inmunología , Transducción de Señal , Transfección , Red trans-Golgi/inmunología , Red trans-Golgi/virologíaRESUMEN
Although human autologous B cells represent a promising alternative to dendritic cells (DCs) for easy large-scale preparation, the naive human B cells are always poor at antigen presentation. The safe and effective usage record of human adenovirus type 7 (HAdV7) live vaccines makes it attractive as a promising vaccine vector candidate. To investigate whether HAdV7 vector could be used to induce the human B cells cross-presentation, in the present study, we constructed the E3-defective recombinant HAdV7 vector encoding green fluorescent protein (GFP) and carcinoembryonic antigen (CEA). We demonstrated that naive human B cells can efficiently be transduced, and that the MAPKs/NF-κB pathway can be activated by recombinant HAdV7. We proved that cytokine TNF-α, IL-6 and IL-10, surface molecule MHC class I and the CD86, antigen-processing machinery (APM) compounds ERp57, TAP-1, and TAP-2. were upregulated in HAdV7 transduced human B cells. We also found that CEA-specific IFNγ expression, degranulation, and in vitro and ex vivo cytotoxicities are induced in autologous CD8(+) T cells presensitized by HAd7CEA modified human B cells. Meanwhile, our evidences clearly show that Toll-like receptors 9 (TLR9) antagonist IRS 869 significantly eliminated most of the HAdV7 initiated B cell activation and CD8(+) T cells response, supporting the role and contribution of TLR9 signaling in HAdV7 induced human B cell cross-presentation. Besides a better understanding of the interactions between recombinant HAdV7 and human naive B cells, to our knowledge, the present study provides the first evidence to support the use of HAdV7-modified B cells as a vehicle for vaccines and immunotherapy.
Asunto(s)
Adenoviridae/genética , Linfocitos B/fisiología , Vacunas contra el Cáncer , Antígeno Carcinoembrionario/metabolismo , Vectores Genéticos/genética , Inmunoterapia , Receptor Toll-Like 9/metabolismo , Proteínas E3 de Adenovirus/genética , Linfocitos T CD8-positivos/inmunología , Vacunas contra el Cáncer/inmunología , Antígeno Carcinoembrionario/genética , Células Cultivadas , Reactividad Cruzada/genética , Citocinas/metabolismo , Citotoxicidad Inmunológica , Humanos , Activación de Linfocitos/genética , FN-kappa B/metabolismo , Transducción de Señal/genética , Transducción GenéticaRESUMEN
Oncolytic adenoviruses can promote immune responses against tumors by expressing and/or displaying tumor-associated antigens. However, the strong immunodominance of viral antigens mask responses against tumor epitopes. In addition, defects in major histocompatibility complex class I antigen presentation pathway such as the downregulation of the transporter-associated with antigen processing (TAP) are frequently associated with immune evasion of tumor cells. To promote the immunogenicity of exogenous epitopes in the context of an oncolytic adenovirus, we have taken advantage of the ER localization of the viral protein E3-19K. We have inserted tumor-associated epitopes after the N-terminal signal sequence for membrane insertion of this protein and flanked them with linkers cleavable by the protease furin to facilitate their TAP-independent presentation. This strategy allowed an enhanced presentation of the exogenous epitopes in TAP-deficient tumor cells in vitro and the generation of higher specific immune responses in vivo that were able to significantly control tumor growth.
Asunto(s)
Transportadoras de Casetes de Unión a ATP/metabolismo , Proteínas E3 de Adenovirus/genética , Adenovirus Humanos/genética , Epítopos/genética , Mutagénesis Insercional , Neoplasias/terapia , Virus Oncolíticos/genética , Adenovirus Humanos/metabolismo , Animales , Presentación de Antígeno , Línea Celular Tumoral , Femenino , Células HEK293 , Humanos , Ratones Endogámicos C57BLRESUMEN
Here we describe a series of replication-defective adenovirus vectors designed to express transgene products from two expression cassettes placed into the deleted E1 and E3 domains. Vectors that contained an E1 cassette with a cytomegalovirus promoter in the forward orientation and an E3 cassette with the chicken ß-actin promoter in the reverse orientation grew to acceptable yields and expressed both transgenes. Additionally, they elicited immune responses to both transgene products. Levels of expression and the vectors' immunogenicity were influenced by the presence of regulatory elements shared between the two expression cassettes. Specifically, vectors that carried the same intron and enhancer in both expression cassettes could be rescued and expanded, but they were poorly immunogenic. Deletion of the enhancer or both the enhancer and the intron from the E3 cassette increased T- and B-cell responses to both transgene products.
Asunto(s)
Adenoviridae/genética , Proteínas E1 de Adenovirus/genética , Proteínas E3 de Adenovirus/genética , Antígenos/genética , Eliminación de Gen , Vectores Genéticos/genética , Transgenes/genética , Adenoviridae/inmunología , Animales , Antígenos/inmunología , Linfocitos T CD8-positivos/inmunología , Línea Celular , Femenino , Expresión Génica , Orden Génico , Vectores Genéticos/inmunología , Genoma Viral , Inestabilidad Genómica , Humanos , Ratones , Transgenes/inmunologíaRESUMEN
Oncolytic viruses based on adenovirus type 5 (Ad5) have been developed as a new class of therapeutic agents for cancers that are resistant to conventional therapies. Clinical experience shows that these agents are safe, but virotherapy alone has not achieved long-term cure in cancer patients. The vast majority of oncolytic adenoviruses used in clinical trials to date have deletion of the E3B genes. It has been demonstrated that the antitumor potency of the E3B-deleted mutant (dl309) is inferior to adenovirus with E3B genes intact. Tumors treated with dl309 show markedly greater macrophage infiltration than E3B-intact adenovirus. However, the functional mechanisms for this were not previously known. Here, we demonstrate that deletion of E3B genes increases production of chemokines by monocytes after adenovirus infection and increases monocyte migration. The E3B 14,700-Da protein (E3B-14.7K) inhibits STAT1 function by preventing its phosphorylation and nuclear translocation. The STAT1 inhibitor, fludarabine, rescues the effect of E3B-14.7K deletion by downregulating target chemokine expression in human and murine monocytes and results in an enhanced antitumor efficacy with dl309 in vivo. These findings have important implications for clinical use of E3B-deleted oncolytic adenovirus and other E3B-deleted adenovirus vector-based therapy.
Asunto(s)
Adenoviridae/fisiología , Proteínas E3 de Adenovirus/metabolismo , Monocitos/metabolismo , Virus Oncolíticos/fisiología , Factor de Transcripción STAT1/metabolismo , Transporte Activo de Núcleo Celular/efectos de los fármacos , Adenoviridae/metabolismo , Proteínas E3 de Adenovirus/genética , Análisis de Varianza , Animales , Western Blotting , Línea Celular , ADN Complementario/biosíntesis , Ensayo de Inmunoadsorción Enzimática , Eliminación de Gen , Humanos , Inmunoprecipitación , Ratones , Microscopía Confocal , Virus Oncolíticos/metabolismo , Fosforilación/efectos de los fármacos , Reacción en Cadena en Tiempo Real de la Polimerasa , Factor de Transcripción STAT1/antagonistas & inhibidores , Vidarabina/análogos & derivados , Vidarabina/farmacologíaRESUMEN
The adenovirus death protein (ADP) is expressed at late times during a lytic infection of species C adenoviruses. ADP promotes the release of progeny virus by accelerating the lysis and death of the host cell. Since some human lymphocytes survive while maintaining a persistent infection with species C adenovirus, we compared ADP expression in these cells with ADP expression in lymphocytes that proceed with a lytic infection. Levels of ADP were low in KE37 and BJAB cells, which support a persistent infection. In contrast, levels of ADP mRNA and protein were higher in Jurkat cells, which proceed with a lytic infection. Epithelial cells infected with an ADP-overexpressing virus died more quickly than epithelial cells infected with an ADP-deleted virus. However, KE37, and BJAB cells remained viable after infection with the ADP-overexpressing virus. Although the levels of ADP mRNA increased in KE37 and BJAB cells infected with the ADP-overexpressing virus, the fraction of cells with detectable ADP was unchanged, suggesting that the control of ADP expression differs between epithelial and lymphocytic cells. When infected with an ADP-deleted adenovirus, Jurkat cells survived and maintained viral DNA for greater than 1 month. These findings are consistent with the notion that the level of ADP expression determines whether lymphocytic cells proceed with a lytic or a persistent adenovirus infection.
Asunto(s)
Infecciones por Adenoviridae/virología , Proteínas E3 de Adenovirus/metabolismo , Adenovirus Humanos/metabolismo , Linfocitos/virología , Proteínas E3 de Adenovirus/genética , Adenovirus Humanos/genética , Línea Celular , Humanos , Liberación del Virus , Replicación ViralRESUMEN
Adenoviral (Ad) vectors are commonly used for various gene therapy applications. Significant advances in the genetic engineering of Ad vectors in recent years has highlighted their potential for the treatment of metastatic disease. There are several methods to genetically modify the Ad genome to incorporate retargeting peptides which will redirect the natural tropism of the viruses, including homologous recombination in bacteria or yeast. However, homologous recombination in yeast is highly efficient and can be achieved without the need for extensive cloning strategies. In addition, the method does not rely on the presence of unique restriction sites within the Ad genome and the reagents required for this method are widely available and inexpensive. Large plasmids containing the entire adenoviral genome (~36 kbp) can be modified within Saccharomyces cerevisiae yeast and genomes easily rescued in Escherichia coli hosts for analysis or amplification. A method for two-step homologous recombination in yeast is described in this chapter.
Asunto(s)
Adenoviridae/genética , Ingeniería Genética/métodos , Vectores Genéticos/genética , Proteínas E3 de Adenovirus/genética , Proteínas de la Cápside/genética , Cromosomas Artificiales Bacterianos/genética , Cromosomas Artificiales de Levadura/genética , Técnicas de Transferencia de Gen , Terapia Genética , Células HEK293 , Recombinación Homóloga , Humanos , Transfección , Transformación Genética , Replicación ViralRESUMEN
First-generation adenovirus vectors (FG AdVs) expressing short-hairpin RNA (shRNA) effectively downregulate the expressions of target genes. However, this vector, in fact, expresses not only the transgene product, but also virus-associated RNAs (VA RNAs) that disturb cellular RNAi machinery. We have established a production method for VA-deleted AdVs lacking expression of VA RNAs. Here, we showed that the highest shRNA activity was obtained when the shRNA was inserted not at the popularly used E1 site, but at the E4 site. We then compared the activities of shRNAs against hepatitis C virus (HCV) expressed from VA-deleted AdVs or conventional AdVs. The VA-deleted AdVs inhibited HCV production much more efficiently. Therefore, VA-deleted AdVs were more effective than the currently used AdVs for shRNA downregulation, probably because of the lack of competition between VA RNAs and the shRNAs. These VA-deleted AdVs might enable more effective gene therapies for chronic hepatitis C.
Asunto(s)
Adenoviridae/genética , Vectores Genéticos/genética , Hepacivirus/genética , Hepatitis C Crónica/terapia , Replicación Viral/genética , Proteínas E1 de Adenovirus/genética , Proteínas E3 de Adenovirus/genética , Proteínas E4 de Adenovirus/genética , Línea Celular , Terapia Genética , Células HEK293 , Hepacivirus/crecimiento & desarrollo , Hepatitis C Crónica/genética , Humanos , Regiones Promotoras Genéticas , Interferencia de ARN , ARN Interferente Pequeño , ARN Viral/biosíntesis , Integración Viral/genéticaRESUMEN
Genes within the E3 transcription unit of human adenoviruses modulate host immune responses to infection. A comprehensive genomics and bioinformatics analysis of the E3 transcription unit for 38 viruses within human adenovirus species D (HAdV-D) revealed distinct and surprising patterns of homologous recombination. Homologous recombination was identified in open reading frames for E3 CR1α, CR1ß, and CR1γ, similar to that previously observed with genes encoding the three major structural capsid proteins, the penton base, hexon, and fiber.
Asunto(s)
Proteínas E3 de Adenovirus/genética , Infecciones por Adenovirus Humanos/genética , Adenovirus Humanos/genética , Proteínas de la Cápside/genética , Recombinación Homóloga , Infecciones por Adenovirus Humanos/virología , Adenovirus Humanos/clasificación , Biología Computacional , ADN Viral/genética , Evolución Molecular , Genoma Viral , Humanos , FilogeniaRESUMEN
Niemann-Pick disease type C (NPC) is caused by mutations in NPC1 or NPC2, which coordinate egress of low-density-lipoprotein (LDL)-cholesterol from late endosomes. We previously reported that the adenovirus-encoded protein RIDα rescues the cholesterol storage phenotype in NPC1-mutant fibroblasts. We show here that RIDα reconstitutes deficient endosome-to-endoplasmic reticulum (ER) transport, allowing excess LDL-cholesterol to be esterified by acyl-CoA:cholesterol acyltransferase and stored in lipid droplets (LDs) in NPC1-deficient cells. Furthermore, the RIDα pathway is regulated by the oxysterol-binding protein ORP1L. Studies have classified ORP1L as a sterol sensor involved in LE positioning downstream of GTP-Rab7. Our data, however, suggest that ORP1L may play a role in transport of LDL-cholesterol to a specific ER pool designated for LD formation. In contrast to NPC1, which is dispensable, the RIDα/ORP1L-dependent route requires functional NPC2. Although NPC1/NPC2 constitutes the major pathway, therapies that amplify minor egress routes for LDL-cholesterol could significantly improve clinical management of patients with loss-of-function NPC1 mutations. The molecular identity of putative alternative pathways, however, is poorly characterized. We propose RIDα as a model system for understanding physiological egress routes that use ORP1L to activate ER feedback responses involved in LD formation.